gvs 111 has been researched along with Cognition Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neznamov, GG; Teleshova, ES | 2 |
| Bochkarev, VK; Davydova, DV; Neznamov, GG; Siuniakov, SA; Teleshova, ES | 1 |
| Dolgova, IN; Starodubtsev, AI | 1 |
| Emelin, AIu; Kudiasheva, AV; Lobzin, VIu; Odinak, MM; Vorob'ev, SV | 1 |
| Amelin, AV; Iliukhina, AIu; Shmonin, AA | 1 |
2 trial(s) available for gvs 111 and Cognition Disorders
| Article | Year |
|---|---|
[Clinical and electroencephalographic characteristic of noopept in patients with mild cognitive impairment of posttraumatic and vascular origin].
Topics: Adult; Brain; Cerebrovascular Circulation; Cognition Disorders; Dipeptides; Electroencephalography; Female; Glycated Hemoglobin; Humans; Male; Neuropsychological Tests; Nootropic Agents; Severity of Illness Index; Stress Disorders, Post-Traumatic | 2008 |
[Noopept in the treatment of mild cognitive impairment in patients with stroke].
Topics: Aged; Aged, 80 and over; Cognition Disorders; Dipeptides; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Stroke; Treatment Outcome | 2011 |
4 other study(ies) available for gvs 111 and Cognition Disorders
| Article | Year |
|---|---|
[A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin].
Topics: Adolescent; Adult; Brain Diseases; Brain Injuries; Cognition Disorders; Dipeptides; Humans; Middle Aged; Neuroprotective Agents; Nootropic Agents; Piracetam; Time Factors; Treatment Outcome | 2008 |
Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin.
Topics: Adolescent; Adult; Brain Diseases; Brain Injuries; Cognition Disorders; Dipeptides; Humans; Middle Aged; Neuroprotective Agents; Nootropic Agents; Piracetam; Time Factors; Treatment Outcome | 2009 |
[Vascular cognitive impairment in young patients].
Topics: Adolescent; Adult; Cerebrovascular Disorders; Cognition Disorders; Dipeptides; Female; Humans; Hypertension; Hypotension; Male; Middle Aged; Treatment Outcome; Young Adult | 2010 |
[Current possibilities in the treatment of posttraumatic cognitive disturbances].
Topics: Adult; Aged; Cognition Disorders; Craniocerebral Trauma; Dipeptides; Female; Humans; Male; Middle Aged; Treatment Outcome; Young Adult | 2011 |